Detection of occult bone metastases of lung cancer with Fluorine-18 fluorodeoxyglucose positron emission tomography

Australasian Radiology

Volumn 48, Issue 2, 2004, Pages 214-216

  Foo, Serene S ^a   Ramdave, Shankar ^a   Berlangieri, Salvatore U ^a   Scott, Andrew M ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

Bone metastases; Lung cancer; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANAMNESIS; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPINE METASTASIS;

BONE NEOPLASMS; FATAL OUTCOME; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3843108068     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2004.01300.x     Document Type: Article

References (8)

1. Jacobson A. Bone scanning in metastatic disease. In: Collier BJ, Fogelman I, Rosenthall L (eds). Skeletal Nuclear Medicine. Mosby, St. Louis, 1996; 87-123.
2. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000; 88 (Suppl. 12); 2927-33.
3. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16: 3375-9.
4. Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro- D-glucose. Radiology 1996; 199: 751-6.
5. Yeh SD, Imbriaco M, Larson SM et al. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol 1996; 23: 693-7.
6. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25: 1244-7.
7. Yamamoto T, Seino Y, Fukumoto H et al. Over-expression of facuitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990; 170: 223-30.
8. Scott AM. Current status of positron emission tomography in oncology. Australas Radiol 2002; 46: 154-62.